Detalhe da pesquisa
1.
Factors associated with non-adherence to medications in systemic lupus erythematosus: Results from a Swedish survey.
Lupus
; 33(6): 615-628, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38545763
2.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.
Ann Rheum Dis
; 82(1): 3-18, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36357155
3.
Using Autoantibodies to Diagnose Systemic Autoimmune Diseases Triggered by Immune Checkpoint Inhibitors: A Clinical Perspective.
Crit Rev Immunol
; 42(4): 21-36, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-37022357
4.
Original research on Behçet's syndrome: a bibliometric analysis over 20 years (2000-2019).
Clin Exp Rheumatol
; 41(10): 1985-1990, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826801
5.
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden.
Rheumatology (Oxford)
; 61(9): 3596-3605, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919663
6.
Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data.
Rheumatology (Oxford)
; 61(10): 3952-3962, 2022 10 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35134119
7.
The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries.
Rheumatology (Oxford)
; 61(9): 3647-3656, 2022 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34940795
8.
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.
Ann Rheum Dis
; 80(8): 1086-1093, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33622688
9.
Validation of new classification criteria of rheumatoid arthritis in an international multicentre study.
Clin Exp Rheumatol
; 38(5): 841-847, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31820726
10.
Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus.
Rheumatology (Oxford)
; 58(12): 2170-2176, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31157891
11.
2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis.
Ann Rheum Dis
; 77(4): 476-479, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29301783
12.
Response to: 'Association of subcutaneous belimumab and long-term antimalarial treatment reduces antiphospholipid antibodies levels in systemic lupus erythematosus: post-hoc analysis of a randomised placebo-controlled trial-comment on: 'Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus' by Chatzidionysiou et al' by Bettiol et al.
Ann Rheum Dis
; 81(8): e141, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32753416
13.
Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1102-1107, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28356243
14.
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2016 update of the EULAR recommendations for the management of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1113-1136, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28283512
15.
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis.
Ann Rheum Dis
; 76(6): 1101-1136, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28298374
16.
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.
Ann Rheum Dis
; 76(6): 960-977, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28264816
17.
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study.
Ann Rheum Dis
; 75(7): 1336-42, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26374404
18.
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.
Rheumatology (Oxford)
; 55(2): 230-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26316581
19.
Effect of belimumab treatment on antiphospholipid antibody levels: post-hoc analysis based on two randomised placebo-controlled trials in systemic lupus erythematosus.
Ann Rheum Dis
; 79(2): 304-307, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31712248
20.
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register.
Ann Rheum Dis
; 74(5): 890-6, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24431398